SMO and basal cell carcinoma: Interestingly, human MBs and basal cell carcinomas (BCCs) are frequently ciliated and abnormal activation of canonical HH signaling, through loss of the HH receptor PTCH1 or activation of SMO, is frequently found in human patients and is sufficient to induce these tumors in mice [21,22].